Literature DB >> 20965159

Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia.

Masafumi Koga1, Kunihiko Hashimoto, Jun Murai, Hiroshi Saito, Mikio Mukai, Kazuhiro Ikegame, Hiroyasu Ogawa, Soji Kasayama.   

Abstract

BACKGROUND: In patients with hemolytic anemia (HA), glycated hemoglobin (HbA(1C)) presents lower values in relation to glycemia because the lifespan of erythrocytes is shortened, whereas glycated albumin (GA) is not affected. In the present study, we examined the usefulness of GA as an indicator of glycemic control status in patients with HA.
METHODS: We enrolled 21 patients with HA. A total of 202 patients with type 2 diabetes mellitus (T2DM) without complications were used as controls.
RESULTS: We identified a significant correlation between GA and HbA(1C) in the patients with HA. However, in a comparison between the patients with HA and those with T2DM, the regression line showed a leftward shift in the former group. There was a significant positive correlation between hemoglobin (Hb) and HbA(1C) in the patients with HA (R=0.541, p=0.025), although there was no significant correlation between Hb and GA. There was an inverse correlation between Hb levels and GA/HbA(1C) ratio (R=-0.710, p=0.001). The measured HbA(1C) levels were lower than the HbA(1C) levels estimated from mean plasma glucose levels, whereas the GA/3 levels were close to the estimated HbA(1C) levels.
CONCLUSIONS: GA is a useful indicator of glycemic control status in patients with HA.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965159     DOI: 10.1016/j.cca.2010.10.014

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

1.  Alterations in HbA1c resulting from the donation of autologous blood for elective surgery in patients with diabetes mellitus.

Authors:  Takeshi Sugimoto; Makoto Hashimoto; Ikuyo Hayakawa; Osamu Tokuno; Tomoko Ogino; Mariko Okuno; Nobuhide Hayashi; Seiji Kawano; Daisuke Sugiyama; Hironobu Minami
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

2.  Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus.

Authors:  S Suzuki; M Koga; S Amamiya; A Nakao; K Wada; K Okuhara; S Hayano; A R Sarhat; H Takahashi; K Matsuo; Y Tanahashi; K Fujieda
Journal:  Diabetologia       Date:  2011-06-05       Impact factor: 10.122

3.  Serum glycated albumin as a new glycemic marker in pediatric diabetes.

Authors:  Ji Woo Lee; Hyung Jin Kim; Young Se Kwon; Yong Hoon Jun; Soon Ki Kim; Jong Weon Choi; Ji Eun Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-12-31

4.  Analytical evaluation of the Diazyme glycated serum protein assay on the siemens ADVIA 1800: comparison of results against HbA1c for diagnosis and management of diabetes.

Authors:  Karina Rodriguez-Capote; Kayla Tovell; Deborah Holmes; Janice Dayton; Trefor N Higgins
Journal:  J Diabetes Sci Technol       Date:  2015-01-14

Review 5.  Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol.

Authors:  Ji-Eun Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-06-30

Review 6.  Haemoglobin A1c or Glycated Albumin for Diagnosis and Monitoring Diabetes: An African Perspective.

Authors:  J A George; R T Erasmus
Journal:  Indian J Clin Biochem       Date:  2018-05-03

Review 7.  Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

Authors:  Christina M Parrinello; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

8.  Shortened mean erythrocyte age in female patients with type 2 diabetes mellitus.

Authors:  Masafumi Koga; Shinya Inada; Hiroko Ijima; Hideaki Jinnouchi; Yasuhiro Ono; Tsuyoshi Iwasaka; Toshika Okumiya
Journal:  J Clin Lab Anal       Date:  2018-10-18       Impact factor: 2.352

9.  Fructosamine measurement for diabetes mellitus diagnosis and monitoring: a systematic review and meta-analysis protocol.

Authors:  Jobert Richie N Nansseu; Joël Fokom-Domgue; Jean Jacques N Noubiap; Eric V Balti; Eugène Sobngwi; André Pascal Kengne
Journal:  BMJ Open       Date:  2015-05-15       Impact factor: 2.692

10.  Estimation of HbA1c response to sitagliptin by change in glycated albumin level for 2 weeks.

Authors:  Tomoya Hamaguchi; Masafumi Koga; Jun Murai; Hiroshi Saito; Daisuke Tamada; Shogo Kurebayashi; Tomoyuki Katsuno; Jun-Ichiro Miyagawa; Mitsuyoshi Namba
Journal:  J Diabetes Investig       Date:  2012-03-28       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.